BioVie Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
BioVie Inc. (BIVI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 1.47 million shares as of 2023-06-30, per its 10-K filed 2023-08-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2023-08-16
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.47M shares.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.14M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.01M shares.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1.11M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2023-06-30 | 1.47M shares 10-K · filed 2023-08-16 |
| 2023-03-31 | 1.14M shares 10-Q · filed 2023-05-12 |
| 2022-12-31 | 1.01M shares 10-Q · filed 2023-02-10 |
| 2022-09-30 | 1.11M shares 10-Q · filed 2022-11-04 |
| 2022-06-30 | 865.77K shares 10-K · filed 2022-09-27 |
| 2022-03-31 | 675.83K shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 509.67K shares 10-Q · filed 2022-02-08 |
| 2021-09-30 | 509.67K shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 236.50K shares 10-K · filed 2021-08-30 |
| 2020-06-30 | 60.00K shares 10-K/A · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |